Hello,
Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:
- Most Omicron cases so far have been mild, but experts still need more data;
- Having severe COVID doubled the chance of dying — even after recovery;
- Long wait times at CVS and Walgreens are delaying COVID-19 vaccines.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @leah_rosenbaum. Let's get to it…
Most Omicron cases so far have been mild, but experts say it will take weeks to understand how severe the variant can be
- Most of the reported cases of COVID-19 associated with the Omicron variant have been mild so far.
- However, experts say it's still too early to observe how the variant affects hospitalization rates and deaths globally.
- Most of the data we have comes from South Africa, a country with a younger and healthier population than the US.
Having severe COVID-19 doubled the chance of dying within a year in a new study — the risk was even higher for young people
- A new study tracked nearly 180 hospitalized COVID-19 patients in Florida for up to a year.
- Adults with severe COVID-19 were twice as likely as uninfected people to die within a year.
- Persistent inflammation may continue to jeopardize patients' health.
The labor shortage is reportedly creating longer COVID-19 vaccine wait times at CVS and Walgreens
- Patients in some states are waiting weeks to get a COVID vaccine at CVS and Walgreens, per WSJ.
- The Omicron variant and new vaccine rules for kids is creating higher demand for jabs.
- Retail pharmacies in states like Connecticut and Kentucky are facing staff shortages.
More stories we're reading:
- Omicron-variant cases have been found in New York and LA, officials say (Insider)
- Doctors in South Africa describe their stories dealing with the Omicron variant (Bloomberg)
- New York governor activates 120 National Guard members to work in nursing homes amid labor shortage (Insider)
- Inside one patient's journey through cognitive therapy after long COVID (The New York Times)
-Leah
Read the original article on Business Insider